Stay updated on Phase 2 DaxibotulinumtoxinA Clinical Trial
Sign up to get notified when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.
Latest updates to the Phase 2 DaxibotulinumtoxinA Clinical Trial page
- Check6 days agoChange DetectedA consolidated Locations section was added listing Georgia, Illinois, Kansas, North Carolina, and Texas, while previous state-specific location entries were removed; the revision updated from v3.3.2 to v3.3.3.SummaryDifference0.7%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of Revision: v3.3.1. This is a minor metadata update and does not alter the study details.SummaryDifference0.1%
- Check35 days agoChange DetectedRevision: v3.3.1 replaced v3.2.0 in the page footer, indicating a minor site update that does not alter study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page no longer displays the government funding/operating status notice that previously appeared in the header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check56 days agoChange DetectedThe update appears cosmetic, affecting layout and styling rather than content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check85 days agoChange DetectedMajor change: updated operating-status notice and new version v3.2.0; removed old version v3.0.2.SummaryDifference5%
Stay in the know with updates to Phase 2 DaxibotulinumtoxinA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.